EICHORCondition: NMIBC · Sponsor: ImmunityBio, Inc.
This expanded access protocol is designed to provide Recombinant Mycobacterium BCG (rMBCG) to patients with Non-muscle invasive bladder cancer (NMIBC) who are eligible to receive TICE® BCG, may benefit from its use, and who are ineligible to participate in a clinical trial using rMBCG, or for other reasons cannot participate (eg, geographically unable to access a study site).
This description comes directly from the study's public registry record.
Jayson Garmizo · 310-912-2230 · jayson.garmizo@immunitybio.com
Always discuss trial participation with your own doctor first.
| Urology Centers of Alabama | Homewood, Alabama, United States | Available |
| University Urology | Mobile, Alabama, United States | Available |
| Urology Associates | Mobile, Alabama, United States | Available |
| Mayo Clinic | Phoenix, Arizona, United States | Available |
| Center for Neurosciences | Tucson, Arizona, United States | Available |
| UC San Diego Moores Cancer Center | La Jolla, California, United States | Available |
| USC/ Norris Comprehensive Cancer Center | Los Angeles, California, United States | Available |
| Urology Center of Southern California | Murrieta, California, United States | Available |
| Saint John's Cancer Institute (Providence) | Santa Monica, California, United States | Available |
| Advent Health Porter | Denver, Colorado, United States | Available |
| MedStar Washington Hospital Center | Washington D.C., District of Columbia, United States | Available |
| Broward Urology Center | Fort Lauderdale, Florida, United States | Available |
+ 54 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06810141